← Eichor
Study identifier: NCT07346326 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparative Study of Functional Outcomes Between Peroneus Longus and Hamstring Tendon Autografts in Arthroscopic ACL Reconstruction

Condition: Anterior Cruciate Ligament Injuries  ·  Sponsor: Khyber Medical University Peshawar

PhaseNA
Planned participants64
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is a prospective, single-blinded, randomized controlled trial. Sixty patients (≥18 years) with an isolated ACL injury will be randomly assigned to receive an ACL reconstruction using either a Peroneus Longus Tendon (PLT) autograft or a Hamstring Tendon (HST) autograft. The primary objective is to compare early functional outcomes between the two groups at 6 weeks and 3 months post-surgery, using the Lysholm Knee Score. The study aims to demonstrate the non-inferiority of the PLT graft. All surgeries will be performed arthroscopically at Khyber Teaching Hospital, Peshawar, followed by a standardized rehabilitation protocol.

This description comes directly from the study's public registry record.

Talk to the study team

Dr Syed Dil Bagh Ali Shah, MBBS  ·  +92-91-9217701  ·  drdilbagh@icloud.com

Dr Syed Muhammad Shabbir Ali Naqvi, MSPT  ·  +923460113227  ·  shabbir_ipmr@kmu.edu.pk

Always discuss trial participation with your own doctor first.

Locations (1)

Khyber Teaching HospitalPeshawar, KPK, PakistanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07346326